This study described the prevalence and risk factors for nonmedical prescription drug use (NMPD) among injection drug users (IDUs) recruited at syringe exchange programs (SEPs) in California. Interviews were conducted with 1,586 IDUs recruited from 24 SEPs across three annual cross-sections between 2001 and 2003. Any NMPD use in the past 6 months was reported by 17% of the sample. Factors independently associated with depressant use include recent participation in a drug treatment program, recent injection of heroin, and frequency of injection. Factors independently associated with opioid use include frequency of injection and history of incarceration. NMPD depressant use increased the odds of a nonfatal overdose in the past year. The authors’ findings represent a first step toward creating an epidemiologic profile of NMPD use that may be useful for targeting the implementation of interventions that are effective in reducing overdoses, a significant cause of mortality among IDUs worldwide.
American Psychological Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
2.
BeckerW.SullivanL.TetraultJ.DesaiR.FiellinD. (2008). Non-medical use, abuse and dependence on prescription opioids among U.S. adults: Psychiatric, medical and substance use correlates. Drug and Alcohol Dependence, 94, 38-47.
3.
BinswangerI. A.SternM. F.DeyoR. A.HeagertyP. J.CheadleA.ElmoreJ. G.KoepsellT. D. (2007). Release from prison—A high risk of death for former inmates. New England Medical Journal, 356, 157-165.
4.
BluthenthalR. N.AndersonR.FlynnN. M.KralA. H. (2007). Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients. Drug and Alcohol Dependence, 84, 423-435.
5.
BoydC. J.McCabeS. E. (2008). Coming to terms with the nonmedical use of prescription medications. Substance Abuse Treatment, Prevention and Policy, 3, 1-3.
6.
DarkeS.WilliamsonA.RossJ.MillsK. L.HavardA. T. (2007). Patterns of nonfatal heroin overdose over a 3-year period: Findings from the Australian treatment outcome study. Journal of Urban Health, 84, 283-291.
7.
DarkeS. M.RossJ. (2000). The use of antidepressants among injecting drug users in Sydney, Australia. Addiction, 95, 407-417.
8.
DavidsonP. J.McLeanR. L.KralA. H.GleghornA. A.EdlinB. R.MossA. R. (2003). Fatal heroin-related overdose in San Francisco, 1997-2000: A case for targeted intervention. Journal of Urban Health, 80, 261-273.
9.
Dowling-GuyerS.JohnsonM. E.FisherD. G.NeedleR.WattersJ. K.AndersenM.. . . TortuS. (1994). Reliability of drug users’ self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment, 1, 383-392.
10.
FastD.SmallW.WoodE.KerrT. (2009). Coming “down here”: Young people’s reflections on becoming entrenched in a local drug scene. Social Science & Medicine, 69, 1204-1210.
11.
HuangB.DawsonD.StinsonF.HasinD.RuanW.SahaT.. . . GrantB. (2006). Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: Results of the National Epidemiologic Survey on alcohol and related conditions. Journal of Clinical Psychiatry, 67, 1062-1073.
12.
KralA. H.AndersonR.FlynnN.BluthenthalR. N. (2004). Injection risk behaviors among clients of syringe exchange programs with different syringe dispensation policies. Journal of Acquired Immune Deficiency Syndromes, 37, 1307-1312.
13.
KroutilL.Van BruntD.Herman-StahlM.HellerD.BrayR.PenneM. (2006). Nonmedical use of prescription stimulants in the United States. Drug and Alcohol Dependence, 15, 135-143.
14.
LankenauS. E.SandersB.BloomJ. J.HathaziD. S.AlarconE.TortuS.ClattsM. (2007). Prevalence and patters of prescription drug misuse among young ketamine injectors. Journal of Drug Issues, 37, 717–736.
15.
McCabeS. E.CranfordJ. A.WestB. T. (2008). Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders, and treatment utilization: Results from two national surveys. Addictive Behaviors, 33, 1297-1305.
16.
MilloyM. J. S.KerrT.MathiasR.ZhangR.MontanerJ. S.TyndallM.WoodE. (2008). Non-fatal overdose among a cohort of active injection drug users recruited from a supervised injection facility. American Journal of Drug and Alcohol Abuse, 34, 499-509.
17.
National Institute on Drug Abuse. (2005). Prescription drugs: Abuse and addiction. Bethesda, MD: National Institutes of Health.
18.
NeedleR. N.FisherD. G.WeatherbyN.ChitwoodD.BrownB.CesariH.. . . BraunsterinM. (1995). Reliability of self-reported HIV risk behaviors of drug users. Psychology of Addictive Behaviors, 9, 242-250.
19.
NovakS.BallJ. (2006). The New DAWN report: Emergency department visits involving nonmedical use of selected pharmaceuticals (Vol. 23). Rockville, MD: SAMHSA.
20.
PolliniR. A.McCallL.MehtaS. H.VlahovD.StrathdeeS. A. (1999). Non-fatal overdose and subsequent drug treatment among injection drug users. Drug and Alcohol Dependence, 83, 104-110.
21.
PowisB.StrangJ.GriffithsP.TaylorC.WilliamsonS.FountainJ.GossopM. (1999). Self-reported overdose among injecting drug users in London: Extent and nature of the problem. Addiction, 94, 471-478.
22.
SealK. H.KralA. H.GeeL.MooreL. D.BluthenthalR. N.LorvickJ.EdlinB. R. (2001). Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area (1998-1999). American Journal of Public Health, 91, 1842-1846.
23.
SeesK. L.Di MarinoM. E.RuedigerN. K.SweeneyC. T.ShiffmanS. (2005). Non-medical use of oxycontin tablets in the United States. Journal of Pain & Palliative Care Pharmacotherapy, 19, 13-23.
24.
SimpsonS.KrishnanL.KunikM.RuizP. (2007). Racial disparities in diagnosis and treatment of depression: A literature review. Psychiatric Quarterly, 78, 3-14.
25.
SporerK. A. (2003). Strategies for preventing heroin overdose. British Medical Journal, 326, 442-444.
26.
Substance Abuse and Mental Health Services Administration. (2006). Drug-related emergency room visits. Rockville, MD: U.S. Department of Health and Human Services.
27.
WakemanS. E.BowmanS. E.McKenzieM.JeronimoA.RichJ. D. (2009). Preventing death among the recently incarcerated: An argument for naloxone prescription before Release. Journal of Addictive Diseases, 28, 124-129.
WeatherbyN.NeedleR. H.CesariH.BoothR.McCoyC. B.WattersJ. K.. . . ChitwoodD. D. (1994). Validity of self-reported drug use among injection drug users recruited through street outreach. Evaluation and Program Planning, 17, 347-355.
30.
WellsK. R.KoikeA.SherbourneC. (2001). Ethnic disparities in unmet need for alcoholism, drug abuse and mental health care. American Journal of Psychology, 158, 2027-2032.
31.
ZacnyJ.BigelowG.ComptonP.FoleyK.IguchiM.SannerundC. (2003). College on problems of drug dependence taskforce on prescription opioid non-medical use and abuse: Position statement. Drug and Alcohol Dependence, 69, 215-232.
